Welcome to our dedicated page for Charlie's Holdings SEC filings (Ticker: CHUC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Charlie’s Holdings, Inc. filings document governance, reporting status and capital-structure actions for a Nevada issuer in the premium vapor-products market. Proxy materials address board matters, executive compensation and pay-versus-performance disclosures.
Current reports describe material definitive agreements and unregistered sales of common stock, including subscription agreements, proceeds for working capital and debt forgiveness consideration. Forms 12b-25 disclose late-filing notices for periodic reports and the company’s stated need for additional time to compile and review required annual and quarterly information.
Charlie's Holdings, Inc. (symbol: CHUC) is the issuer of record for a Form 4 filing submitted to the SEC. SICIGNANO HENRY III reported acquisition or exercise transactions in this Form 4 filing.
Charlie's Holdings, Inc. (CHUC) reported that President Henry Sicignano III received a grant of 500,000 shares of restricted common stock on September 3, 2026, at a stated price of $0.00 per share. The grant was made under the company’s 2019 Omnibus Equity Incentive Plan and vests in two equal annual installments, subject to continued service. Following this award, he holds 10,350,001 shares directly and 100,000 shares indirectly through an IRA. No Rule 10b5-1 trading plan is reported.
Charlie's Holdings, Inc. (symbol: CHUC) is the issuer of record for a Form 4 filing submitted to the SEC. Montesano Matthew P reported acquisition or exercise transactions in this Form 4 filing.
Charlie's Holdings, Inc. (CHUC) reported that its Chief Financial Officer, Matthew P. Montesano, received a grant of 500,000 shares of Common Stock on September 3, 2026 as a stock award. The award was granted at a stated price of $0.00 per share.
The filing states these shares are restricted stock issued under the company’s 2019 Omnibus Equity Incentive Plan, vesting in two equal annual installments on the first and second anniversaries of the grant, subject to continued service. After this grant, Montesano holds 3,325,409 Common shares directly.
Charlie's Holdings, Inc. (symbol: CHUC) is the issuer of record for a Form 4 filing submitted to the SEC. Stump Ryan reported acquisition or exercise transactions in this Form 4 filing.
Charlie's Holdings, Inc. (CHUC) reported that Chief Operating Officer Ryan Stump received a grant of 200,000 shares of common stock on September 3, 2026 as a compensation award. The shares vest on the one-year anniversary of the grant, subject to continued service. After the grant he holds 2,551,968 shares directly and 27,349,787 shares indirectly through the Ryan Stump Legacy Trust. No Rule 10b5-1 trading plan is reported.
Charlie's Holdings, Inc. (symbol: CHUC) is the issuer of record for a Form 4 filing submitted to the SEC. King Michael D reported acquisition or exercise transactions in this Form 4 filing.
Charlie's Holdings, Inc. (CHUC) director Michael D. King received a grant of 200,000 shares of common stock on September 3, 2026 as a compensation-related award at a stated price of $0.00 per share. These shares will vest on the one-year anniversary of the grant, subject to continued service, and he now directly holds 6,950,001 common shares. No Rule 10b5-1 trading plan is reported for this award.
Charlie's Holdings, Inc. (symbol: CHUC) is the issuer of record for a Form 4 filing submitted to the SEC. Fox Jeffrey G reported acquisition or exercise transactions in this Form 4 filing.
Charlie's Holdings, Inc. (CHUC) reported that director Jeffrey G. Fox received a grant of 200,000 shares of common stock on September 3, 2026. The shares were granted at $0.00 per share and will vest on the one-year anniversary of the grant, subject to continued service, bringing his direct holdings to 1,650,000 shares.
Charlie's Holdings, Inc. (symbol: CHUC) is the issuer of record for a Form 4 filing submitted to the SEC. Cohen Scot reported acquisition or exercise transactions in this Form 4 filing.
Charlie's Holdings, Inc. (CHUC) reported that director Scot Cohen received a grant of 200,000 shares of common stock on September 3, 2026 as a share award, at no cash cost. After this award, he holds 1,438,000 shares directly. The granted shares will vest on the one-year anniversary of the grant, subject to continued service, and no Rule 10b5-1 trading plan is reported in connection with this transaction.
Charlie's Holdings, Inc. (CHUC) reported that director Edward Carmines received a grant of 200,000 shares of Common Stock on September 3, 2026, classified as a grant or award acquisition. The shares will vest on the one-year anniversary of the grant, subject to continued service.
After this award, Carmines holds 2,356,481 shares of Common Stock directly and 100,000 shares indirectly through a FamilyTrust.
Charlie’s Holdings, Inc. reported strong top-line growth but continued losses for the quarter ended June 30, 2026. Product revenue rose to $3.8 million from $1.8 million a year earlier, and six‑month revenue increased to $8.6 million from $3.3 million, driven largely by nicotine-based and SBX alternative alkaloid vapor products. Gross profit for the first half improved to $2.3 million, but higher general and administrative plus sales and marketing costs led to a six‑month operating loss of $2.2 million and a net loss from continuing operations of $2.7 million.
Liquidity remains tight. Cash was $0.5 million at June 30, 2026, with net cash used in continuing operating activities of $1.5 million in the first half. Working capital improved to $4.7 million, helped by equity raises in February and May totaling $10.9 million of common shares at $0.20 per share (combined consideration, including cash and settlement of debt and payables). Total assets were $12.8 million and stockholders’ equity was $3.1 million; notes payable totaled $2.15 million, mainly a $2.0 million secured note due 2027 and a $150,000 SBA disaster loan.
The company operates in a highly regulated environment. Its subsidiary is challenging FDA Marketing Denial Orders on certain nicotine and synthetic nicotine products; court-ordered stays currently keep affected PMTAs in pending status, allowing continued sales where state law permits. Management highlights growth plans around SBX Metatine‑based products, expansion of PACHA/Pachamama brands, development of AI‑based age‑gating technology, and international sales. Despite ongoing losses, management believes the company is adequately capitalized to meet obligations for at least the next twelve months.
Charlie’s Holdings, Inc. notified the SEC that it will not file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 by the prescribed deadline. The company states the delay is due to needing additional time for compilation and review to ensure adequate disclosure of required information. It expects to file the Form 10-Q within the five-calendar-day extension period permitted under Rule 12b-25.
Charlie’s Holdings, Inc. announced leadership changes and a sharpened strategic focus on age-gated vapor products. Co‑founder and Chief Operating Officer Ryan Stump notified the Board he will resign as COO effective September 4, 2026, citing no disagreements, while remaining on the Board to lead strategic partnership initiatives.
The Board appointed Henry Sicignano III as Chief Executive Officer, effective August 4, 2026; he continues as President with compensation unchanged. Company representatives highlighted plans to launch disposable vapes with device access restrictions using licensed age‑gating technology and to pursue partnerships to monetize a 678‑sku Premarket Tobacco Application portfolio.